Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Athira Pharma Inc. logo

Athira Pharma Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

1.78
 
USD
  
0.03
  
(1.42%)
Optionable: Yes  Market Cap: 67 M  90-day average vol: 177,080

Previous close: 1.755  Open: 1.75  Bid: 1.66  Ask: 1.89
52 week range    
1.33   
   4.41
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 7th December 2023
41
MarketXLS Rank
40
Value
61
Technical
23
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

ATHA Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22
Basic EPS from continuing operations-1.49
Basic EPS total-1.49-2.53
Basic weighted shares outstanding12 M37 M38 M
Depreciation-2000.0479000.0-845000.0
DepreciationAndAmortization-2000.0479000.0-845000.0
Diluted EPS total-1.67-1.49-2.53
Diluted normalized net income/share-1.67
Diluted weighted shares outstanding12 M37 M38 M
GeneralAndAdministrativeExpense7 M21 M33 M
Income before tax-21 M-64 M-101 M
Interest income124000.0337000.0
InterestExpenseNonOperating-367000.03000.0
MiscOtherSpecialCharges-1 M334000.03 M
Net income from total operations-20 M-55 M-96 M
NetIncomeCommonStockholders-20 M-55 M-96 M
NetIncomeContinuousOperations-20 M-55 M-96 M
NetIncomeFromOtherGainsLosses1 M9 M5 M
NetNonOperatingInterestIncomeExpense491000.0334000.0
NonRecurringOperationExpense10 M
Operating income-20 M-64 M-94 M
Operating income before depreciation (EBITDA)-21 M-63 M-100 M
OperatingExpense20 M64 M94 M
Other income net1 M-334000.0-3 M
OtherGandA7 M21 M33 M
OtherOperatingExpenses323000.0
RentAndLandingFees33 M
Research & development expense13 M43 M61 M
ResearchExpense13 M43 M61 M
SalariesAndWages-633000.0-11 M
Selling Gen & administrative expense7 M21 M33 M
Special income/charges-10 M
Total Income available for interest expense (EBIT)-22 M-64 M-101 M
Total common shares outstanding37 M38 M38 M
Total net income-20 M-55 M-96 M
Total ordinary shares38 M38 M38 M
TotalExpenses20 M64 M94 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today